NASDAQ:EDAP - Edap Tms Stock Price, Price Target & More

Get Started

$2.39 -0.01 (-0.42 %)

(As of 05/25/2018 04:00 PM ET)

Previous Close$2.40

Today's Range$2.35 - $2.40

52-Week Range$2.07 - $3.85

Volume34,753 shs

Average Volume46,205 shs

Market Capitalization$70.75 million

P/E Ratio-239.00

Dividend YieldN/A

Beta0.74

About Edap Tms (NASDAQ:EDAP)

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology. It offers Ablatherm, a HIFU device for the treatment of organ-confined prostate cancer, referred to as T1-T2 stage; and Focal One device, a HIFU robotic device for the focal therapy of localized prostate cancer. This division also leases equipment; sells disposables and spare parts; and offers maintenance services. The UDS division develops, manufactures, markets, and services medical devices for the minimally invasive diagnosis or treatment of urological disorders primarily urinary stones and other clinical indications. It offers lithotripters, such as Sonolith i-move and Sonolith i-sys for the treatment of urinary tract stones by means of extracorporeal shockwave lithotripsy technology. This division also leases lithotripters; sells disposables and spare parts; and provides maintenance services. The company markets and sells its products through its direct marketing and sales organization, as well as through third-party distributors and agents. Its customers include public and private hospitals, urology clinics, and research institutions. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

Receive EDAP News and Ratings via Email

Sign-up to receive the latest news and ratings for EDAP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

SymbolNASDAQ:EDAP

CUSIPN/A

Webwww.edap-tms.com

Phone33-04-72-15-31-50

Debt

Debt-to-Equity Ratio0.05

Current Ratio2.45

Quick Ratio2.04

Price-To-Earnings

Trailing P/E Ratio-239.00

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$40.74 million

Price / Sales1.70

Cash Flow$0.0446 per share

Price / Cash53.64

Book Value$0.98 per share

Price / Book2.44

Profitability

EPS (Most Recent Fiscal Year)($0.01)

Net Income$-760,000.00

Net Margins-5.98%

Return on Equity-5.89%

Return on Assets-3.22%

Miscellaneous

Employees197

Outstanding Shares29,000,000

Edap Tms (NASDAQ:EDAP) Frequently Asked Questions

What is Edap Tms' stock symbol?

Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."

How were Edap Tms' earnings last quarter?

Edap Tms SA (NASDAQ:EDAP) released its quarterly earnings results on Monday, May, 14th. The medical equipment provider reported $0.03 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.02) by $0.05. The medical equipment provider had revenue of $11.28 million for the quarter, compared to analyst estimates of $10.46 million. Edap Tms had a negative net margin of 5.98% and a negative return on equity of 5.89%. View Edap Tms' Earnings History.

When is Edap Tms' next earnings date?

Edap Tms is scheduled to release their next quarterly earnings announcement on Wednesday, August, 22nd 2018. View Earnings Estimates for Edap Tms.

What price target have analysts set for EDAP?

1 analysts have issued 1-year target prices for Edap Tms' shares. Their predictions range from $6.50 to $6.50. On average, they anticipate Edap Tms' share price to reach $6.50 in the next twelve months. View Analyst Ratings for Edap Tms.

What are Wall Street analysts saying about Edap Tms stock?

Here are some recent quotes from research analysts about Edap Tms stock:

1. HC Wainwright analysts commented, "We have adjusted our financial model to reflect the reported 1Q18 financial results. For 2018, we project revenues of approximately €39.0M and a net loss of €0.01 per share. The company reported €18.1M in cash, cash equivalents and short- term investments as of March 31, which we believe is sufficient to fund operations for the foreseeable future." (5/16/2018)
2. According to Zacks Investment Research, "EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors. " (4/10/2018)

Who are some of Edap Tms' key competitors?

Some companies that are related to Edap Tms include Vision Sciences (CGNT), Helius Medical Technologies (HSDT), Fonar (FONR), Second Sight Medical Products (EYES), Biolife Solutions (BLFS), Zynex (ZYXI), IRIDEX (IRIX), Semler Scientific (SMLR), BioSig Technologies (BSGM), Viveve Medical (VIVE), Stereotaxis (STXS), Soleno Therapeutics (SLNO), Digirad (DRAD), Dynatronics (DYNT) and Nexeon MedSystems (NXNN).

Who are Edap Tms' key executives?

Edap Tms' management team includes the folowing people:

Mr. Marc Oczachowski, CEO & Director (Age 48)
Mr. Franois Dietsch, Chief Financial Officer (Age 42)
Mrs. Blandine Confort, Investor Relations Officer and Sec.
Ms. Judith Johannsen, Sales Director for Germany Austria & Switzerland and Gen. Mang. of Edap Gmbh
Mr. John Cameron Rewcastle, VP of Strategic Devel. (Age 44)

Has Edap Tms been receiving favorable news coverage?

News stories about EDAP stock have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Edap Tms earned a news sentiment score of 0.18 on Accern's scale. They also gave media coverage about the medical equipment provider an impact score of 44.78 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next few days.

Who are Edap Tms' major shareholders?

Edap Tms' stock is owned by a number of of retail and institutional investors. Top institutional investors include Archon Capital Management LLC (3.51%). View Institutional Ownership Trends for Edap Tms.

Which major investors are buying Edap Tms stock?

EDAP stock was purchased by a variety of institutional investors in the last quarter, including Archon Capital Management LLC. View Insider Buying and Selling for Edap Tms.

How do I buy shares of Edap Tms?

Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Edap Tms' stock price today?

One share of EDAP stock can currently be purchased for approximately $2.39.

How big of a company is Edap Tms?

Edap Tms has a market capitalization of $70.75 million and generates $40.74 million in revenue each year. The medical equipment provider earns $-760,000.00 in net income (profit) each year or ($0.01) on an earnings per share basis. Edap Tms employs 197 workers across the globe.

How can I contact Edap Tms?

Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]

MarketBeat Community Rating for Edap Tms (EDAP)

Community Ranking:		2.7 out of 5 ( )
Outperform Votes:		176 (Vote Outperform)
Underperform Votes:		154 (Vote Underperform)
Total Votes:		330

MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote "Outperform" if you believe EDAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Edap Tms (NASDAQ:EDAP) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for Edap Tms in the last 12 months. Their average twelve-month price target is $6.50, suggesting that the stock has a possible upside of 171.97%. The high price target for EDAP is $6.50 and the low price target for EDAP is $6.50. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	3.00	3.00	3.00	3.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 1 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$6.50	$7.00	$6.50	$6.50
Price Target Upside:	171.97% upside	218.18% upside	123.37% upside	123.37% upside

Edap Tms (NASDAQ:EDAP) Consensus Price Target History

Price Target History for Edap Tms (NASDAQ:EDAP)

Edap Tms (NASDAQ:EDAP) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
5/16/2018	HC Wainwright	Reiterated Rating	Buy	$6.50	Medium

(Data available from 5/25/2016 forward)

Edap Tms (NASDAQ:EDAP) Earnings History and Estimates Chart

Earnings by Quarter for Edap Tms (NASDAQ:EDAP)

Edap Tms (NASDAQ:EDAP) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.01 EPS

Edap Tms (NASDAQ EDAP) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/22/2018
5/14/2018	3/31/2018	($0.02)	$0.03	$10.46 million	$11.28 million	View	Listen
3/27/2018	Q4	$0.01	$0.01	$12.87 million	$12.60 million	View	Listen
11/15/2017	Before Market	($0.02)	($0.02)	$11.05 million	$8.44 million	View	N/A
8/23/2017	6/30/2017	($0.02)	($0.05)	$10.00 million	$10.40 million	View	N/A
5/17/2017	Q1	($0.03)	$0.13	$9.35 million	$9.29 million	View	N/A
4/3/2017	Q4 2016		($0.03)	$12.25 million	$11.44 million	View	N/A
11/17/2016	9/30/2016		($0.01)	$10.14 million	$8.94 million	View	N/A
8/25/2016	Q2 2016	($0.03)	$0.03	$8.52 million	$9.18 million	View	N/A
5/18/2016	Q1 2016	($0.02)	$0.04	$7.71 million	$9.63 million	View	N/A
4/4/2016	Q4 2015		$0.05	$9.07 million	$12.76 million	View	N/A
11/18/2015	Q3 2015		($0.02)	$8.90 million	$7.13 million	View	N/A
8/26/2015	Q215	($0.05)	($0.02)	$7.58 million	$8.70 million	View	Listen
5/12/2015	Q115	$0.03	($0.1110)	$9.25 million	$6.89 million	View	N/A
4/1/2015	Q414	($0.01)	($0.07)	$11.28 million	$8.00 million	View	N/A
11/20/2014	Q314	($0.03)	$0.01		$9.00 million	View	N/A
8/28/2014	Q2 14	($0.04)	($0.32)	$10.32 million	$7.70 million	View	N/A
5/15/2014	Q114	($0.04)	$0.05	$9.30 million	$10.60 million	View	N/A
4/3/2014	Q4	($0.06)	($0.04)		$11.05 million	View	Listen
11/21/2013	Q3	($0.06)	($0.02)	$9.46 million	$7.40 million	View	Listen
8/28/2013	Q2 2013	($0.05)	($0.01)	$7.80 million	$5.90 million	View	N/A
5/16/2013	Q1 2013		($0.16)		$7.80 million	View	N/A
4/2/2013	Q4 2012		($0.05)			View	N/A
11/21/2012	-0.03		($0.03)		$7.10 million	View	N/A
8/30/2012	Q2 2012		($0.19)			View	N/A
5/16/2012	Q1 2012		($0.11)			View	N/A
3/21/2012	Q4 2011		($0.06)			View	N/A
11/16/2011	Q3 2011	($0.12)	$0.09			View	N/A
8/30/2011	Q2 2011	($0.11)	($0.16)			View	N/A
5/24/2011	Q1 2011	($0.10)	($0.09)			View	N/A
3/29/2011	Q4 2010	($0.16)	($0.18)			View	N/A
11/17/2010	Q3 2010	($0.18)	($0.22)			View	N/A
8/24/2010	Q2 2010	($0.05)	($0.12)			View	N/A
5/18/2010	Q1 2010	($0.11)	($0.32)			View	N/A
3/30/2010	Q4 2009	($0.01)	$0.23			View	N/A
11/17/2009	Q3 2009	($0.12)	($0.80)			View	N/A
5/13/2009	Q1 2009	($0.20)	($0.26)			View	N/A
3/31/2009	Q4 2008	$0.04	$0.01			View	N/A
11/20/2008	Q3 2008		($0.63)			View	N/A
8/21/2008	Q2 2008	($0.21)	($0.35)			View	N/A
5/15/2008	Q1 2008	($0.24)	($0.42)			View	N/A
3/26/2008	Q4 2007	($0.17)	($0.19)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Edap Tms (NASDAQ:EDAP) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Edap Tms (NASDAQ EDAP) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 9.67%

Insider Trading History for Edap Tms (NASDAQ:EDAP)

Institutional Ownership by Quarter for Edap Tms (NASDAQ:EDAP)

Edap Tms (NASDAQ EDAP) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

Edap Tms (NASDAQ EDAP) News Headlines

Source:

Date	Headline
	EDAP May 2018 2.000 call finance.yahoo.com - May 18 at 9:52 AM
	Edap Tms (EDAP) Downgraded by TheStreet to D+ www.americanbankingnews.com - May 17 at 2:55 PM
	Edap Tms' (EDAP) "Buy" Rating Reaffirmed at HC Wainwright www.americanbankingnews.com - May 16 at 1:49 PM
	Edap Tms (EDAP) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS www.americanbankingnews.com - May 16 at 9:56 AM
	EDAP TMS SA : EDAP Reports 2018 First Quarter Results globenewswire.com - May 16 at 9:28 AM
	EDAP's (EDAP) CEO Marc Oczachowski on Q1 2018 Results - Earnings Call Transcript seekingalpha.com - May 16 at 9:28 AM
	Was EDAP TMS SA.’s (NASDAQ:EDAP) Earnings Decline Part Of A Broader Industry Downturn? finance.yahoo.com - May 15 at 5:02 PM
	Zacks: Brokerages Set $6.50 Price Target for Edap Tms S.A. (EDAP) www.americanbankingnews.com - May 13 at 7:20 PM
	Edap Tms (EDAP) to Release Quarterly Earnings on Monday www.americanbankingnews.com - May 7 at 4:08 AM
	Theraclion: First Echopulse® System Sale Recorded for Use in The French “Forfait Innovation” www.businesswire.com - May 4 at 4:36 PM
	Edap Tms (EDAP) Downgraded by ValuEngine to "Sell" www.americanbankingnews.com - May 3 at 10:55 PM
	EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14 finance.yahoo.com - May 2 at 4:42 PM
	Form 20-F EDAP TMS SA For: Dec 31 www.streetinsider.com - May 1 at 4:34 PM
	Reviewing Edap Tms (EDAP) & Echo Therapeutics (ECTE) www.americanbankingnews.com - April 26 at 8:04 AM
	Edap Tms S.A. (EDAP) Given $6.50 Consensus Target Price by Brokerages www.americanbankingnews.com - April 24 at 3:12 PM
	Edap Tms (EDAP) versus EnteroMedics (RSLS) Financial Survey www.americanbankingnews.com - April 24 at 5:26 AM
	Biolife Solutions (BLFS) vs. Edap Tms (EDAP) Head to Head Analysis www.americanbankingnews.com - April 11 at 5:33 AM
	Edap Tms (EDAP) Upgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 10 at 11:04 PM
	Analysts Anticipate Edap Tms S.A. (EDAP) to Announce ($0.02) EPS www.americanbankingnews.com - April 9 at 1:19 PM
	After-Hours Stock Movers 04/03: (EDAP) (HCC) (AEHR) Higher; (CLDR) (PLAY) (CLLS) Lower (more...) www.streetinsider.com - April 4 at 4:51 PM
	Free Research Report as Globus Achieved Record Quarterly Revenues; Adjusted EPS Rose 20.6% finance.yahoo.com - April 4 at 4:51 PM
	EDAP TMS SA : EDAP Reports First US Cohort Study Results of Focal HIFU Prostate Ablation Shows Promising Outcomes finance.yahoo.com - April 3 at 4:40 PM
	Financial Comparison: Edap Tms (EDAP) & Sunshine Heart (CHFS) www.americanbankingnews.com - March 31 at 3:18 PM
	ValuEngine Lowers Edap Tms (EDAP) to Sell www.americanbankingnews.com - March 31 at 2:40 PM
	Edap Tms (EDAP) Downgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - March 31 at 12:31 PM
	Edap Tms (EDAP) Stock Rating Lowered by Zacks Investment Research www.americanbankingnews.com - March 29 at 8:30 PM
	Edap Tms (EDAP) Given a $7.00 Price Target by HC Wainwright Analysts www.americanbankingnews.com - March 29 at 11:06 AM
	Edap Tms (EDAP) Releases Earnings Results, Meets Expectations www.americanbankingnews.com - March 28 at 4:12 PM
	EDAP TMS S.A. misses by $0.02, misses on revenue seekingalpha.com - March 28 at 9:30 AM
	EDAP TMS SA : EDAP Reports 2017 Annual Results globenewswire.com - March 28 at 9:30 AM
	Earnings Scheduled For March 27, 2018 www.benzinga.com - March 27 at 4:31 PM
	EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private ... - GlobeNewswire (press release) globenewswire.com - March 21 at 4:44 PM
	EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure feeds.benzinga.com - March 21 at 6:32 AM
	Edap Tms (EDAP) Scheduled to Post Earnings on Tuesday www.americanbankingnews.com - March 20 at 1:32 AM
	EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018 - GlobeNewswire (press release) globenewswire.com - March 16 at 9:32 AM
	EDAP TMS SA : EDAP TMS to Announce Year End 2017 Financial Results on Tuesday, March 27, 2018 feeds.benzinga.com - March 14 at 3:03 PM
	Edwards Lifesciences (EW) vs. Edap Tms (EDAP) Critical Comparison www.americanbankingnews.com - March 7 at 11:15 AM
	Contrasting Edap Tms (EDAP) and Synergetics USA (SURG) www.americanbankingnews.com - February 27 at 9:18 PM
	Comparing Edap Tms (EDAP) & Mindray Medical International (MR) www.americanbankingnews.com - January 28 at 5:14 PM
	Edap Tms (EDAP) Cut to "Hold" at Zacks Investment Research www.americanbankingnews.com - January 19 at 10:10 PM
	Edap Tms (EDAP) Upgraded to "Buy" by Zacks Investment Research www.americanbankingnews.com - January 18 at 10:54 PM
	Analysts Anticipate Edap Tms SA (EDAP) to Post $0.01 Earnings Per Share www.americanbankingnews.com - January 17 at 12:04 PM
	Short Interest in Edap Tms SA (EDAP) Decreases By 36.5% www.americanbankingnews.com - January 15 at 4:40 AM
	Edap Tms (EDAP) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - January 11 at 12:52 AM
	EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey finance.yahoo.com - December 18 at 9:44 AM
	The global tumor ablation market is expected to grow with a CAGR of 10.5% over the period of 2017 - 2023 www.bizjournals.com - December 1 at 4:48 PM
	Edap Tms (EDAP) Upgraded by Zacks Investment Research to "Buy" www.americanbankingnews.com - November 28 at 9:20 PM
	Contrasting Agilent Technologies (A) & Edap Tms (EDAP) www.americanbankingnews.com - November 27 at 3:58 PM
	Zacks: Edap Tms S.A. (EDAP) Receives Consensus Rating of "Strong Buy" from Analysts www.americanbankingnews.com - November 27 at 11:26 AM
	HC Wainwright Reaffirms Buy Rating for Edap Tms S.A. (EDAP) www.americanbankingnews.com - November 22 at 4:26 PM

Edap Tms (NASDAQ:EDAP) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Edap Tms (NASDAQ:EDAP) Income Statement, Balance Sheet and Cash Flow Statement

Edap Tms (NASDAQ EDAP) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff